Stephan Polterauer - Gynecology

Author Information

Stephan Polterauer is affiliated with the Department of Obstetrics and Gynecology at the Comprehensive Cancer Center (CCC), Medical University of Vienna, located in Vienna, Austria. His research primarily focuses on gynecologic oncology, particularly in ovarian and cervical cancers.

Research Contributions

Stephan Polterauer has made significant contributions to the field of gynecologic oncology through various research studies. In 2022, he published papers on topics such as the real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer, the influence of the pretreatment controlling nutritional status score in ovarian cancer, and the comparison of topical imiquimod with conization for treating cervical high-grade squamous intraepithelial lesions. In 2021, his research included studies on the reliability of tumor testing compared to germline testing for BRCA1 and BRCA2 mutations, the association of a combined cancer exhaustion score with circulating tumor cells, and outcomes in ovarian cancer, among others. His work has provided valuable insights into the treatment and management of gynecologic cancers.

Aliases

Stephan Polterauer is also known by the aliases S Polterauer and S. Polterauer.

Publication and Citation Metrics

Citation Count	3261
H-Index	31
Paper Count	168

Publications:

Austria-based real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer

DOI: 10.1007/s00508-022-02005-2

Year: 2022

The Pretreatment Controlling Nutritional Status Score in Ovarian Cancer: Influence on Prognosis, Surgical Outcome, and Postoperative Complication Rate

DOI: 10.1055/a-1608-1309

Year: 2022

Topical imiquimod compared with conization to treat cervical high-grade squamous intraepithelial lesions: Multicenter, randomized controlled trial.

DOI: 10.1016/j.ygyno.2022.01.033

Year: 2022

Reliability of Tumor Testing Compared to Germline Testing for Detecting BRCA1 and BRCA2 Mutations in Patients with Epithelial Ovarian Cancer

DOI: 10.3390/jpm11070593

Year: 2021

Association of a Combined Cancer Exhaustion Score with Circulating Tumor Cells and Outcome in Ovarian Cancer—A Study of the OVCAD Consortium

DOI: 10.3390/cancers13235865

Year: 2021

Surgical, Oncological and Obstetric Outcomes After Radical Abdominal Trachelectomy for Early-Stage Cervical Cancer at a Single Tertiary Center.

DOI: 10.21203/RS.3.RS-456708/V1

Year: 2021

Long-term survival in multiresistant metastatic choriocarcinoma after pembrolizumab treatment: A case report

DOI: 10.1016/j.gore.2021.100817

Year: 2021

Overweight as a Favorable Clinical Biomarker for Checkpoint Inhibitor Therapy Response in Recurrent Gynecologic Cancer Patients

DOI: 10.3390/biom11111700

Year: 2021

PD-1 and PD-L1 expression on TILs in peritoneal metastases compared to ovarian tumor tissues and its associations with clinical outcome

DOI: 10.1038/s41598-021-85966-0

Year: 2021

Nomogram predicting overall survival in locally advanced cervical cancer patients treated by radio-chemotherapy including image guided brachytherapy: a Retro-EMBRACE study.

DOI: 10.1016/j.ijrobp.2021.04.022

Year: 2021

What is Amiloride?

What are some preventive measures for reproductive health issues?

How Does Liletta Compare to Other IUDs?

What are the Legal Implications of Non-Compliance?

What to Expect During a Pelvic Exam?

What is Ice Therapy?

What Are the Common Complications of Unsafe Abortions?

How Can Women Prepare for Gynecological Screening?

What are the Symptoms of Cervicitis?

What Are Some Challenges in Implementing Cultural Competency in Gynecology?

Partnered Content Networks

Relevant Topics